Medical News

RSS

Agencies mark World Food Day, call for increased transparency in commodity markets

At a ceremony marking World Food Day on Monday, the U.N. Food and Agriculture Organization (FAO) "called for more transparency on commodity markets to prevent sharp spikes in global food prices and deplored the scale of world hunger," Agence France-Presse reports.

18 Oct 2011

Obese children require much smaller doses of anesthetic propofol

A study presented at ANESTHESIOLOGY 2011 this week found that obese children required much smaller doses of the anesthetic propofol than non-obese children to bring about a safe level of unconsciousness.

18 Oct 2011

Accera identifies genetic profile of AD patients with heightened response to Axona

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.

18 Oct 2011

St. Jude Medical commences use of renal denervation catheter and generator system

St. Jude Medical, Inc., a global medical device company, today announced the first use of the company's renal denervation catheter and generator system, as part of a feasibility study of the new technology. The technology was developed as a treatment for resistant hypertension (high blood pressure that is not well controlled by drug therapy).

18 Oct 2011

FDA approves Oxford BioMedica's UshStat IND to treat Usher syndrome type 1B

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.

18 Oct 2011

Whole genome sequencing study to determine causes of idiopathic human diseases

Scripps Health announced today it has launched an innovative clinical research study that is using whole genome sequencing to help determine the causes of idiopathic human diseases -- those serious, rare and perplexing health conditions that defy a diagnosis or are unresponsive to standard treatments.

18 Oct 2011

TPP, University of Dundee sign collaboration agreement for drug development fund

TPP Global Development Ltd announced a collaboration agreement with the University of Dundee to establish a drug development fund.

18 Oct 2011

Gender differences in sexuality should not be taken at face value

In the racy television hit show, Sex and the City, Carrie, one of the main characters tells her best girlfriends that "Men who are too good looking are never good in bed because they never had to be."

18 Oct 2011

Facing national deficit while preserving foreign assistance

Noting some of the successes of U.S. foreign assistance in the area of global health, Christopher Elias, president and CEO of PATH, and Richard Stearns, president of World Vision U.S., write in The Hill's "Congress Blog," "Unfortunately, ... American aid is being threatened with severe cuts, though it makes up less than one percent of the federal budget."

18 Oct 2011

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.

18 Oct 2011

Circadian disruption and sleep restriction increase risk of MS in teens

Researchers from Sweden have uncovered an association between shift work and increased risk of multiple sclerosis. Those who engage in off-hour employment before the age of 20 may be at risk for MS due to a disruption in their circadian rhythm and sleep pattern. Findings of this novel study appear today in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society.

18 Oct 2011

NIH awards Einstein College of Medicine $5.7M for children's IDD Research Center

The Eunice Kennedy Shriver National Institute for Child Health and Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University $5.7 million to fund the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC).

18 Oct 2011

U.S. NGOs call for Obama administration to explain delays in U.S. food aid to North Korea

"As South Korean President Lee Myung-bak continued his state visit to the United States on Friday, a group of nongovernmental organizations (NGOs) wants the Obama administration to explain what they call unconscionable delays in deciding whether to resume U.S. food assistance to North Korea," Reuters reports.

18 Oct 2011

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program.

18 Oct 2011

Natroba effective against head lice and nits

ParaPRO, LLC, announced that researchers have presented data showing the effectiveness of Natroba (spinosad) Topical Suspension, 0.9% against head lice and nits following one treatment without nit combing. Those data about the pediculicide, derived from a naturally-occurring soil bacterium, were presented in a poster session on Saturday, Oct. 15, 2011 at the American Academy of Pediatrics National Conference and Exhibition in Boston.

18 Oct 2011

Obese asthmatic children more likely to have respiratory complications during or after surgery

A study presented at ANESTHESIOLOGY 2011 found that obese asthmatic children were nearly two times as likely to have at least one respiratory complication during or after surgery compared to their lean peers.

18 Oct 2011

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.

18 Oct 2011

LRI launches major lupus research initiative

The Lupus Research Institute (LRI) launched a major international initiative aimed at attracting the highest level scientists to conduct pioneering research to discover the fundamental root causes of lupus, explore the potential for a cure, and transform the field of lupus research.

18 Oct 2011

Globe and Mail reports on death of Zambian HIV/AIDS advocate Winstone Zulu

Toronto's Globe and Mail reports on the death on Thursday of Winstone Zulu, an HIV/AIDS advocate from Zambia who lived with the virus for two decades. "His death has devastated the international community of AIDS activists," the newspaper writes.

18 Oct 2011

AHRQ: Asthma drug usage among children doubles

The proportion of children who used a prescribed controller drug to treat their asthma doubled from 29 percent in 1997-1998 to 58 percent in 2007-2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

18 Oct 2011

Medical News

Agencies mark World Food Day, call for increased transparency in commodity markets

Obese children require much smaller doses of anesthetic propofol

Accera identifies genetic profile of AD patients with heightened response to Axona

St. Jude Medical commences use of renal denervation catheter and generator system

FDA approves Oxford BioMedica's UshStat IND to treat Usher syndrome type 1B

Whole genome sequencing study to determine causes of idiopathic human diseases

TPP, University of Dundee sign collaboration agreement for drug development fund

Gender differences in sexuality should not be taken at face value

Facing national deficit while preserving foreign assistance

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Circadian disruption and sleep restriction increase risk of MS in teens

NIH awards Einstein College of Medicine $5.7M for children's IDD Research Center

U.S. NGOs call for Obama administration to explain delays in U.S. food aid to North Korea

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Natroba effective against head lice and nits

Obese asthmatic children more likely to have respiratory complications during or after surgery

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

LRI launches major lupus research initiative

Globe and Mail reports on death of Zambian HIV/AIDS advocate Winstone Zulu

AHRQ: Asthma drug usage among children doubles

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News